Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms

Author:

Wang Yong1,Zhang Liang1,Qi Lin1,Yi Xiaoping2,Li Minghao1,Zhou Mao3,Chen Danlei1,Xiao Qiao1,Wang Cikui1,Pang Yingxian1,Xu Jiangyue4,Deng Hao1,Liu Longfei1ORCID,Guan Xiao1

Affiliation:

1. Department of Urology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan, China

2. Department of Radiology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan, China

3. Department of Clinical Laboratory, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan, China

4. Department of Minimally Invasive Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China

Abstract

Endocrine neoplasms remain a great threat to human health. It is extremely important to make a clear diagnosis and timely treatment of endocrine tumors. Machine learning includes radiomics, which has long been utilized in clinical cancer research. Radiomics refers to the extraction of valuable information by analyzing a large amount of standard data with high-throughput medical images mainly including computed tomography, positron emission tomography, magnetic resonance imaging, and ultrasound. With the quantitative imaging analysis and model building, radiomics can reflect specific underlying characteristics of a disease that otherwise could not be evaluated visually. More and more promising results of radiomics in oncological practice have been seen in recent years. Radiomics may have the potential to supplement traditional imaging analysis and assist in providing precision medicine for patients. Radiomics had developed rapidly in endocrine neoplasms practice in the past decade. In this review, we would introduce the general workflow of radiomics and summarize the applications and developments of radiomics in endocrine neoplasms in recent years. The limitations of current radiomic research studies and future development directions would also be discussed.

Funder

National Natural Science Foundation of China

Publisher

Hindawi Limited

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3